Literature DB >> 25701514

The European patient advocacy perspective on specialist breast units and accreditation.

Susan Knox1.   

Abstract

Europa Donna--The European Breast Cancer Coalition has been advocating for all women to have access to care in specialist breast units since 2003. Two European Parliament Resolutions, (2003 and 2006) as well as the Written Declaration against breast cancer in the EU of 2010 called on member states to ensure that all women in the European Union have access to treatment in such units set up in accordance with the "European Guidelines for quality assurance in breast cancer screening and diagnosis," by 2016. Once mammography screening implementation according to EU Guidelines commenced, it became evident that it would be essential to have high-quality units where women would receive specialised treatment upon diagnosis. Europa Donna was a member of the revision committee for Chapter 9 of the 4th edition of these Guidelines (2006) which provided a detailed description of these services as previously defined by EUSOMA. Moreover, the 2010 Written Declaration on the fight against breast cancer in the EU called on the Commission "to develop a certification protocol for specialist breast units in accordance with EU Guidelines by 2011". The most important thing for a woman diagnosed with breast cancer to know is where to go to get the best treatment, i.e. she needs to know that the clinic or unit is accredited as having implemented appropriate quality standards that meet EU Guidelines thus ensuring provision of high level breast services, and that her national health system will pay for it. Progress on accomplishing this has not moved quickly, nor has it been accepted by all stakeholders involved.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Accreditation; Best practice; Breast cancer advocacy; Multidisciplinary team; Quality assurance; Specialist breast units

Mesh:

Year:  2015        PMID: 25701514     DOI: 10.1016/j.breast.2015.01.013

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  2 in total

1.  Global Practice and Efficiency of Multidisciplinary Tumor Boards: Results of an American Society of Clinical Oncology International Survey.

Authors:  Nagi S El Saghir; Raghid N Charara; Firas Y Kreidieh; Vanessa Eaton; Kate Litvin; Rania A Farhat; Katia E Khoury; Juliana Breidy; Hani Tamim; Toufic A Eid
Journal:  J Glob Oncol       Date:  2015-10-28

2.  A New Software Platform to Improve Multidisciplinary Tumor Board Workflows and User Satisfaction: A Pilot Study.

Authors:  Elizabeth A Krupinski; Merce Comas; Leia Garrote Gallego
Journal:  J Pathol Inform       Date:  2018-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.